Prestige Consumer Healthcare logo

Prestige Consumer HealthcareNYSE: PBH

Profile

Sector:

Healthcare

Country:

United States

IPO:

10 February 2005

Next earnings report:

02 August 2024

Last dividends:

27 September 2018

Next dividends:

N/A
$3.37 B
-9%vs. 3y high
87%vs. sector
-9%vs. 3y high
29%vs. sector
-12%vs. 3y high
58%vs. sector
-8%vs. 3y high
48%vs. sector

Price

after hours | Wed, 03 Jul 2024 18:50:43 GMT
$67.55-$0.73(-1.07%)

Dividend

No data over the past 3 years
$276.99 M$260.55 M
$276.99 M$49.46 M

Analysts recommendations

Institutional Ownership

PBH Latest News

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
globenewswire.com02 July 2024 Sentiment: -

TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
zacks.com16 May 2024 Sentiment: NEGATIVE

Prestige Consumer's (PBH) Q4 performance is negatively affected by supply chain challenges, leading to difficulties in meeting retailer demand.

Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research14 May 2024 Sentiment: POSITIVE

While the revenue and EPS of Prestige Consumer Healthcare (PBH) provide insight into its quarterly performance ending in March 2024, it may be beneficial to also analyze how certain important metrics stack up against Wall Street predictions and figures from the previous year.

Prestige Consumer Healthcare (PBH) Misses Q4 Earnings and Revenue Estimates
Zacks Investment Research14 May 2024 Sentiment: NEGATIVE

Prestige Consumer Healthcare (PBH) reported quarterly earnings of $1.02 per share, falling short of the Zacks Consensus Estimate of $1.14 per share. This is lower than the earnings of $1.07 per share reported in the same quarter last year.

Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
Zacks Investment Research19 April 2024 Sentiment: POSITIVE

Investors can look forward to strong performance from Prestige Consumer's (PBH) varied portfolio.

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Zacks Investment Research08 April 2024 Sentiment: POSITIVE

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
Zacks Investment Research02 April 2024 Sentiment: POSITIVE

Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Momentum Stock
Zacks Investment Research25 March 2024 Sentiment: POSITIVE

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
Zacks Investment Research21 March 2024 Sentiment: POSITIVE

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Reasons to Retain Prestige Consumer (PBH) Stock for Now
Zacks Investment Research05 March 2024 Sentiment: POSITIVE

Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.

  • 1(current)
  • 2

What type of business is Prestige Consumer Healthcare?

Prestige Consumer Healthcare Inc. is engaged in the production and distribution of over-the-counter medical products. The company has a wide range of medical products, including pain relievers, dermatological products, cold remedies, products for eye, ear, oral, gastrointestinal health, as well as products for women's health. The company's portfolio includes pain relief powders under the BC/Goody brand, Boudreaux's Butt Paste children's ointments, Chloraseptic sore throat lozenges, Clear Eyes products for reducing eye redness. In addition, the company offers wart removal products, earwax removal products, as well as enemas, stomach upset remedies, Monistat vaginal antifungal products and Nix lice and parasite treatments. The company was founded in 1996, with its headquarters located in Tarrytown, New York.

What sector is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Healthcare sector

What industry is Prestige Consumer Healthcare in?

Prestige Consumer Healthcare is in the Drug Manufacturers - Specialty & Generic industry

What country is Prestige Consumer Healthcare from?

Prestige Consumer Healthcare is headquartered in United States

When did Prestige Consumer Healthcare go public?

Prestige Consumer Healthcare initial public offering (IPO) was on 10 February 2005

What is Prestige Consumer Healthcare website?

https://www.prestigebrands.com

Is Prestige Consumer Healthcare in the S&P 500?

No, Prestige Consumer Healthcare is not included in the S&P 500 index

Is Prestige Consumer Healthcare in the NASDAQ 100?

No, Prestige Consumer Healthcare is not included in the NASDAQ 100 index

Is Prestige Consumer Healthcare in the Dow Jones?

No, Prestige Consumer Healthcare is not included in the Dow Jones index

When does Prestige Consumer Healthcare report earnings?

The next expected earnings date for Prestige Consumer Healthcare is 02 August 2024